Author:
Zhou Jia,Hirota Keiji,Ackermann Rose,Walker Jennifer,Wang Yan,Choi Stephanie,Schwendeman Anna,Schwendeman Steven P.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev. 1997;28(1):43–70.
2. Plosker GL, Brogden RN. Leuprorelin. Drugs. 1994;48(6):930–67.
3. Annual reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. United States Securities and Exchange Commission.
4. 21 CFR 314.94(a)(9)(iii).
5. Wang Y, Wen Q, Choi SH. FDA’s regulatory science program for generic PLA/PLGA-based drug products. Am Pharm Rev. 2016;19(4):5–9.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献